Cargando…
Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
OBJECTIVE: Shikonin is a natural product with many activities, including anti-cancer effects. Pyruvate kinase type M2 (PKM2) plays a crucial role in the growth of tumor cells. However, the effect of shikonin on PKM2 in hepatocellular carcinoma (HCC) is unclear. METHODS: Cell viability, apoptosis lev...
Autores principales: | Liu, Tong, Li, Sainan, Wu, Liwei, Yu, Qiang, Li, Jingjing, Feng, Jiao, Zhang, Jie, Chen, Jiaojiao, Zhou, Yuting, Ji, Jie, Chen, Kan, Mao, Yuqing, Wang, Fan, Dai, Weiqi, Fan, Xiaoming, Wu, Jianye, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035901/ https://www.ncbi.nlm.nih.gov/pubmed/32110554 http://dx.doi.org/10.2147/JHC.S237614 |
Ejemplares similares
-
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
por: Feng, Jiao, et al.
Publicado: (2019) -
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
por: Feng, Jiao, et al.
Publicado: (2020) -
Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
por: Wu, Liwei, et al.
Publicado: (2019) -
Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis
por: Feng, Jiao, et al.
Publicado: (2019) -
Alleviation of Hepatic Ischemia Reperfusion Injury by Oleanolic Acid Pretreating via Reducing HMGB1 Release and Inhibiting Apoptosis and Autophagy
por: Wang, Wenwen, et al.
Publicado: (2019)